Melanie C. Dispenza, Ph.D.
Affiliations: | 2011 | Pennsylvania State University, State College, PA, United States |
Area:
ImmunologyGoogle:
"Melanie Dispenza"Parents
Sign in to add mentor| Diane Thiboutot | grad student | 2011 | Penn State | |
| (Immunomodulatory effects of isotretinoin in vivo.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dispenza MC, Bochner BS. (2018) Diagnosis and Novel Approaches to the Treatment of Hypereosinophilic Syndromes. Current Hematologic Malignancy Reports |
| Dispenza MC, Pongracic JA, Singh AM, et al. (2018) Short term ibrutinib therapy suppresses skin test responses and eliminates IgE-mediated basophil activation in adults with peanut or tree nut allergy. The Journal of Allergy and Clinical Immunology |
| Dispenza MC, Pongracic JA, Singh AM, et al. (2018) Administration of two doses of an oral, irreversible inhibitor of Bruton’s tyrosine kinase (BTK) to food allergic adults abrogates skin test responses and eliminates IgE-mediated basophil activation ex vivo The Journal of Allergy and Clinical Immunology. 141 |
| Dispenza MC, Regan JA, Bochner B. (2017) Potential applications of Bruton's tyrosine kinase inhibitors for the prevention of allergic reactions. Expert Review of Clinical Immunology |
| Regan JA, Cao Y, Dispenza MC, et al. (2017) Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity. The Journal of Allergy and Clinical Immunology |
| Regan JA, Petrich AM, Dispenza MC, et al. (2017) Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity in allergic cancer patients receiving drug The Journal of Allergy and Clinical Immunology. 139 |
| Nelson AM, Dispenza MC, Cong Z, et al. (2016) Selective Rho Kinase Inhibitor Allows for Expansion of Human Primary Sebocytes In Vitro. The Journal of Investigative Dermatology |
| Dispenza MC, Wolpert EB, Gilliland KL, et al. (2012) Systemic isotretinoin therapy normalizes exaggerated TLR-2-mediated innate immune responses in acne patients. The Journal of Investigative Dermatology. 132: 2198-205 |